BME Company Profile and Key Details

BlackRock Health Sciences Trust (NYSE:BME) closed at $44.22 USD, gaining $0.16 (0.36%) from the previous close of $44.06. The stock is currently within 5% of its 52-week high $35.95 and $46.43. With a market capitalization of about $571.50 million, BlackRock Health Sciences Trust is classified as a small-cap and shows lower-than-market volatility (beta ~0.59). Key stats such as the average daily volume over the past year has been around 45.17 thousand shares, volume is running light vs its 52-week average. Headquartered in New York, NY, BlackRock Health Sciences Trust operates in the Financial Services sector and the Asset Management industry. BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States.

Short-term trend indicators are bearishly aligned (SMA20 0.61%, SMA50 1.39%, SMA200 10.29%). The stock’s 14-day RSI is 56.82 (neutral), while the ATR of 0.5 points to moderate volatility. The stock remains sitting in the mid-range of its 52-week band, trading -0.77% below its high and over 23.76% above its low. Average 10-day trading volume of 38.22 thousand shares is below the 3-month average of 44.73 thousand, indicating normal recent market interest.

BlackRock Health Sciences Trust last paid a dividend of 3.15 per share, this equals a trailing yield of roughly 7.11%. Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $1.23. This means the shares are trading above this model’s fair value.

currently trading near 52-week highs band. Valuation shows BlackRock Health Sciences Trust trading at a premium to the broader market with a P/E of 5.5.

Our AI price prediction model suggests that BlackRock Health Sciences Trust stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

BlackRock Health Sciences Trust trades at a P/E ratio of 5.5, slightly below the S&P 500 average, with a price-to-sales ratio of 10.7 and a price-to-book ratio of 1.0 suggesting the stock is closer to book value. The P/FCF stands at 23.03, also above market averages.